International Journal of Medical and Pharmaceutical Research
2023, Volume-4, Issue-2 doi: 10.5281/zenodo.7772209
Original Article
Different Doses of Intravenous Ondansetron With Placebo on Attenuation of Spinal-induced Hypotension
 ,
 ,
 ,
Published
March 26, 2023
Abstract
Introduction: Spinal anesthesia is a simple, reliable, and most common anesthetic technique practiced worldwide. However, spinal anesthesia is associated with side effects such as hypotension, bradycardia, and shivering. Hypotension is most common intraoperative complication during spinal anaesthesia for caesarean section which has detrimental effects on both mother and fetus. Objective: To compare the effect of intravenous ondansetron with placebo for attenuation of spinal induced hypotension, change in heart rate, requirement for vasopressor and incidence of shivering and postoperative nausea- vomiting. Methods: A prospective randomised double blind study was conducted at Department of Anesthesia, Monno Medical College & Hospital, Manikganj, Bangladesh from July to December 2022. Total 100 patients belonging to ASA Class-I and II, aged 25-35 years, weight 40-60 kilograms, undergoing cesarean delivery under spinal anesthesia were included in this study. Group O (n=50) received 6mg ondansetron in normal saline intravenously; total volume made 10ml. Group S (n=50) received 10ml normal saline intravenously. Patient with history of PIH, convulsion, compromised airway or morbid obesity and required general anaesthesia for supplementation were excluded from study. Blood pressure and heart rate were checked every 5minutes till the end of the surgery. Data was analyzed by chi square test. Results: Total 100 patients were investigated for the effect of prophylactic ondansetron 6mg intravenously on fall in SBP, DBP and MBP, number of vasopressor boluses and total dose of vasopressor required. Distribution of cases according to age was comparable (p-0.339) in both groups (ondansetron group-25.27±3.62 and normal saline group- 24.63±3.60). In both groups maximum patients were below 25yrs old. We also studied the effect of ondansetron on the level of sensory height, duration of subarachnoid block to start of surgery, duration of surgery, heart rate, incidence of nausea, shivering and bradycardia. Systolic, diastolic and mean blood pressure were found to be higher in group O as compare to group S at different time intervals (p value < 0.05). In group O 66% patients required vasopressors whereas in group S 90% patients required vasopressors. Incidence of nausea and vomiting is less in group O (p-value=0.001). Conclusion: we conclude that prophylactic use of intravenous ondansetron prevent incidence of hypotension and less vasopressor is required to treat hypotension. Prophylactic ondansetron use is associated with less incidence of nausea and vomiting in spinal anesthesia in healthy parturient.
Recommended Articles
Loading Image...
Volume-4, Issue-2
Citations
650 Views
403 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved